Cargando…

Characterization of the circulating transcriptome expression profile and identification of novel miRNA biomarkers in hypertrophic cardiomyopathy

BACKGROUND: Hypertrophic cardiomyopathy (HCM), one of the most common genetic cardiovascular diseases, but cannot be explained by single genetic factors. Circulating microRNAs (miRNAs) are stable and highly conserved. Inflammation and immune response participate in HCM pathophysiology, but whether t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Lanyan, Cai, Yue, Wang, Bo, Zhang, Fuyang, Zhao, Hang, Liu, Liwen, Tao, Ling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314611/ https://www.ncbi.nlm.nih.gov/pubmed/37391825 http://dx.doi.org/10.1186/s40001-023-01159-7

Ejemplares similares

Identifying Obstructive Hypertrophic Cardiomyopathy from Nonobstructive Hypertrophic Cardiomyopathy: Development and Validation of a Model Based on Electrocardiogram Features
por: Guo, Lanyan, et al.
Publicado: (2023)

Novel biomarkers identifying hypertrophic cardiomyopathy and its obstructive variant based on targeted amino acid metabolomics
por: Guo, Lanyan, et al.
Publicado: (2022)

Circulating Biomarkers in Hypertrophic Cardiomyopathy
por: Matthia, Eldon L., et al.
Publicado: (2022)

Derivation and Validation of a Screening Model for Hypertrophic Cardiomyopathy Based on Electrocardiogram Features
por: Guo, Lanyan, et al.
Publicado: (2022)

A Novel miRNA Screen Identifies miRNA-4454 as a Candidate Biomarker for Ventricular Fibrosis in Patients with Hypertrophic Cardiomyopathy
por: Thottakara, Tilo, et al.
Publicado: (2021)

Identification of Potential miRNA-mRNA Regulatory Network Contributing to Hypertrophic Cardiomyopathy (HCM)
por: Wang, Lin, et al.
Publicado: (2021)

Systematic identification and analysis of dysregulated miRNA and transcription factor feed‐forward loops in hypertrophic cardiomyopathy
por: Shi, Hongbo, et al.
Publicado: (2018)

MiRNA-Regulated Pathways for Hypertrophic Cardiomyopathy: Network-Based Approach to Insight into Pathogenesis
por: Osmak, German, et al.
Publicado: (2021)

miRNA Transcriptome of Hypertrophic Skeletal Muscle with Overexpressed Myostatin Propeptide
por: Javed, Ruheena, et al.
Publicado: (2014)

Circulating miRNAs as Potential Biomarkers Associated with Cardiac Remodeling and Fibrosis in Chagas Disease Cardiomyopathy
por: Nonaka, Carolina Kymie Vasques, et al.
Publicado: (2019)

Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy
por: Fang, Lu, et al.
Publicado: (2015)

Novel Genes Involved in Hypertrophic Cardiomyopathy: Data of Transcriptome and Methylome Profiling
por: Kiselev, Ivan, et al.
Publicado: (2022)

Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures
por: Duttagupta, Radha, et al.
Publicado: (2011)

Circulating and Cardiac Tissue miRNAs in Children with Dilated Cardiomyopathy
por: Hailu, Frehiwet T., et al.
Publicado: (2023)

Circulating miR-499a-5p Is a Potential Biomarker of MYH7—Associated Hypertrophic Cardiomyopathy
por: Baulina, Natalia, et al.
Publicado: (2022)

Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach
por: Becker, Svetlana, et al.
Publicado: (2016)

Identification of Cardiomyopathy-Associated Circulating miRNA Biomarkers in Muscular Dystrophy Female Carriers Using a Complementary Cardiac Imaging and Plasma Profiling Approach
por: Florian, Anca, et al.
Publicado: (2018)

Identification of circulating miRNA biomarkers based on global quantitative real-time PCR profiling
por: Kang, Kang, et al.
Publicado: (2012)

Bioinformatics analysis of the regulatory lncRNA-miRNA-mRNA network and drug prediction in patients with hypertrophic cardiomyopathy
por: Li, Jiajianghui, et al.
Publicado: (2019)

Circulating miRNA Biomarkers for Alzheimer's Disease
por: Kumar, Pavan, et al.
Publicado: (2013)

Circulating miRNAs as Biomarkers for Neurodegenerative Disorders
por: Grasso, Margherita, et al.
Publicado: (2014)

Circulating miRNAs as biomarkers of kidney disease
por: Hüttenhofer, Alexander, et al.
Publicado: (2017)

Dysregulation of circulating miRNAs promotes the pathogenesis of diabetes-induced cardiomyopathy
por: Ahmed, Uzair, et al.
Publicado: (2021)

Heterogeneous circulating miRNA profiles of PBMAH
por: Hara, Kazunari, et al.
Publicado: (2022)

CMR feature tracking strain patterns and their association with circulating cardiac biomarkers in patients with hypertrophic cardiomyopathy
por: Cavus, Ersin, et al.
Publicado: (2021)

Transcriptome analysis of arterial and venous circulating miRNAs during hypertension
por: Jin, Ling, et al.
Publicado: (2021)

Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy
por: Ho, Jennifer E, et al.
Publicado: (2017)

DNA methylome and transcriptome profiling reveal key electrophysiology and immune dysregulation in hypertrophic cardiomyopathy
por: Li, Xiaoyan, et al.
Publicado: (2023)

Cell-free Circulating miRNA Biomarkers in Cancer
por: Mo, Meng-Hsuan, et al.
Publicado: (2012)

Methodological challenges in utilizing miRNAs as circulating biomarkers
por: Moldovan, Leni, et al.
Publicado: (2014)

Challenges in Using Circulating miRNAs as Cancer Biomarkers
por: Tiberio, Paola, et al.
Publicado: (2015)

Circulating miRNAs as Diagnostic Biomarkers for Parkinson’s Disease
por: Roser, Anna Elisa, et al.
Publicado: (2018)

Differential expression profiles of miRNA in granulomatous lobular mastitis and identification of possible biomarkers
por: Ling, Jie, et al.
Publicado: (2022)

Comment on ‘Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'—Methodological challenges in combining miRNAs as circulating biomarkers
por: Verderio, P, et al.
Publicado: (2016)

Circulating miRNA-23b and miRNA-143 Are Potential Biomarkers for In-Stent Restenosis
por: Saavedra, Nicolás, et al.
Publicado: (2020)

Genetic profile of hypertrophic cardiomyopathy in Tunisia: Is it different?
por: Jaafar, Nawel, et al.
Publicado: (2015)

Hearing Profile in Patients with Dilated and Hypertrophic Cardiomyopathies
por: El-Zarea, Gehan Abd El-Rahman, et al.
Publicado: (2016)

miRNA transcriptome and myofiber characteristics of lamb skeletal muscle during hypertrophic growth(1)
por: Greene, M. A., et al.
Publicado: (2022)

Hypertrophic cardiomyopathy
por: Antunes, Murillo de Oliveira, et al.
Publicado: (2020)

Hypertrophic Cardiomyopathy
por: Butt, Asra K., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_di7orv3tq2frqqk0hj0iib9b4h